Efficacy and safety of Denosumab treatment for osteoporosis in patients with primary biliary cholangitis; a randomized controlled trial with zoledronic acid (DELTA Study)
Latest Information Update: 26 Aug 2022
At a glance
- Drugs Denosumab (Primary) ; Zoledronic acid
- Indications Osteoporosis
- Focus Therapeutic Use
- Acronyms DELTA Study
- 25 Aug 2022 Status changed from recruiting to completed.
- 26 Apr 2018 Status changed from not yet recruiting to recruiting.
- 21 Feb 2018 New trial record